ArticleJournal for immunotherapy of cancer2022

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab.

Geoffrey Alan Watson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.